BioSpace News Archive

Return Ready worksite vaccination clinics in operation with more than a dozen employers and poised to help additional employers as vaccination eligibility has expanded to all adults and supply is more readily available

Viatris Inc. announced the company will take part in a virtual fireside chat at the BofA Securities 2021 Health Care Conference on Tuesday, May 11, 2021.

Artio Medical, Inc. , a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced today the closing of an additional $12 million tranche of Series A financing

Perflow Medical, a private, Israeli-based innovator for neurovascular treatments, today announced the first successful clinical use of the Stream™17 Dynamic Neuro-Thrombectomy Net, a lower profile device designed for more tortuous anatomy, to effectively treat hemorrhagic and ischemic stroke patients.

CANbridge to lead development and commercialization in China; expands rare disease pipeline Mirum is entitled to receive up to an aggregate of $120.0 million in upfront and milestone payments, and significant double-digit tiered royalties

Bristol Myers Squibb (NYSE:BMY) today reports results for the first quarter of 2021, which reflect continued sales growth and advancement of the company’s product pipeline across our four core therapeutic areas.

Repertoire Immune Medicines, a clinical-stage biotech company decoding the immune synapse to create novel immune therapies for cancer, immune disorders, infectious disease, and other serious diseases, today announced a new collaboration with Yale University focused on understanding the basis of cellular immunity of multiple sclerosis (MS) by determining what types of antigens are activating T cells in patients.

A notable number of DES approvals by Food and Drug Administration, China Food and Drug Administration, Japanese Ministry of Health, and other such regulatory authorities is driving growth in the global drug-eluting stents market.

Transparency Market Research delivers key insights on the global digital dose inhalers market.

Transparency Market Research has published a new report on the global cell separation technology market for the forecast period of 2019–2027.